• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病研究的挑战:环境触发因素。

Challenges in IBD Research: Environmental Triggers.

机构信息

University of Cincinnati, Cincinnati, Ohio.

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S13-S23. doi: 10.1093/ibd/izz076.

DOI:10.1093/ibd/izz076
PMID:31095702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6787673/
Abstract

Environmental triggers is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, novel technologies, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of a multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the environmental triggers section is focused on the main research gaps in elucidating causality of environmental factors in IBD. Research gaps were identified in: 1) epidemiology of exposures; 2) identification of signatures of biological response to exposures; and 3) mechanisms of how environmental exposures drive IBD. To address these gaps, the implementation of longitudinal prospective studies to determine disease evolution and identify sub-clinical changes in response to exposures is proposed. This can help define critical windows of vulnerability and risk prediction. In addition, systems biology analysis and in silico modeling were proposed as approaches to integrate the IBD exposome for the identification of biological signatures of response to exposures, and to develop prediction models of the effects of environmental factors in driving disease activity and response to therapy. This research could lead to identification of biomarkers of exposures and new modalities for therapeutic intervention. Finally, hypothesis-driven mechanistic studies to understand gene-environment interactions and to validate causality of priority factors should be performed to determine how environment influences clinical outcomes.

摘要

环境触发因素是《炎症性肠病研究挑战》文件五个重点关注领域之一,其他四个领域分别为临床前人类 IBD 发病机制、新技术、精准医学和实用临床研究。《炎症性肠病研究挑战》文件全面概述了当前炎症性肠病研究中的空白,并提出了切实可行的解决方案。该文件由来自科学家、临床医生、患者和资助者的多学科人员共同参与完成,是患者为中心的研究重点确定的宝贵资源。特别是,环境触发因素部分重点关注阐明环境因素在 IBD 中因果关系的主要研究空白。研究空白包括:1)暴露的流行病学;2)识别暴露生物反应的特征;3)环境暴露驱动 IBD 的机制。为了解决这些空白,建议实施纵向前瞻性研究以确定疾病演变并识别暴露反应的亚临床变化。这有助于确定脆弱和风险预测的关键窗口期。此外,还提出了系统生物学分析和计算机建模作为方法,用于整合 IBD 外显子组以识别对暴露的生物反应特征,并开发环境因素对疾病活动和治疗反应影响的预测模型。这一研究可能会发现暴露的生物标志物,并为治疗干预提供新方法。最后,应进行假设驱动的机制研究以了解基因-环境相互作用并验证优先因素的因果关系,以确定环境如何影响临床结果。

相似文献

1
Challenges in IBD Research: Environmental Triggers.炎症性肠病研究的挑战:环境触发因素。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S13-S23. doi: 10.1093/ibd/izz076.
2
Challenges in IBD Research: Precision Medicine.炎症性肠病研究的挑战:精准医学。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S31-S39. doi: 10.1093/ibd/izz078.
3
Challenges in IBD Research: Pragmatic Clinical Research.炎症性肠病研究面临的挑战:实用临床研究。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S40-S47. doi: 10.1093/ibd/izz085.
4
Challenges in IBD Research: Preclinical Human IBD Mechanisms.炎症性肠病研究面临的挑战:临床前人类 IBD 机制。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S5-S12. doi: 10.1093/ibd/izz075.
5
Challenges in IBD Research: Novel Technologies.炎症性肠病研究的挑战:新技术。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S24-S30. doi: 10.1093/ibd/izz077.
6
Challenges in IBD Research 2024: Precision Medicine.2024 年炎症性肠病研究面临的挑战:精准医学。
Inflamm Bowel Dis. 2024 May 23;30(Suppl 2):S39-S54. doi: 10.1093/ibd/izae084.
7
Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms.2024 年炎症性肠病研究面临的挑战:临床前人类 IBD 机制。
Inflamm Bowel Dis. 2024 May 23;30(Suppl 2):S5-S18. doi: 10.1093/ibd/izae081.
8
The Search for Causative Environmental Factors in Inflammatory Bowel Disease.炎症性肠病致病环境因素的探寻
Dig Dis. 2016;34 Suppl 1:48-55. doi: 10.1159/000447283. Epub 2016 Aug 22.
9
Challenges in IBD Research 2024: Environmental Triggers.2024 年炎症性肠病研究面临的挑战:环境诱因。
Inflamm Bowel Dis. 2024 May 23;30(Suppl 2):S19-S29. doi: 10.1093/ibd/izae085.
10
Challenges in IBD Research 2024: Novel Technologies.2024 年炎症性肠病研究面临的挑战:新技术。
Inflamm Bowel Dis. 2024 May 23;30(Suppl 2):S30-S38. doi: 10.1093/ibd/izae082.

引用本文的文献

1
Gut Feeling: Biomarkers and Biosensors' Potential in Revolutionizing Inflammatory Bowel Disease (IBD) Diagnosis and Prognosis-A Comprehensive Review.直觉:生物标志物和生物传感器在革新炎症性肠病(IBD)诊断和预后方面的潜力——全面综述
Biosensors (Basel). 2025 Aug 7;15(8):513. doi: 10.3390/bios15080513.
2
Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases.炎症性肠病发病机制的新见解
Biomedicines. 2025 Jan 26;13(2):305. doi: 10.3390/biomedicines13020305.
3
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies.炎症性肠病在先进治疗时代的年龄分布流行病学。
J Crohns Colitis. 2024 Oct 30;18(Supplement_2):ii3-ii15. doi: 10.1093/ecco-jcc/jjae082.
4
Fermented Soymilk with Probiotic and Strains Ameliorates Dextran-Sulfate-Sodium-Induced Colitis in Rats.发酵豆乳与益生菌和菌株改善葡聚糖硫酸钠诱导的大鼠结肠炎。
Nutrients. 2024 Oct 14;16(20):3478. doi: 10.3390/nu16203478.
5
Risk of inflammatory bowel disease following hospitalisation with infectious mononucleosis: nationwide cohort study from Denmark.传染性单核细胞增多症住院后发生炎症性肠病的风险:来自丹麦的全国队列研究。
Nat Commun. 2024 Sep 27;15(1):8383. doi: 10.1038/s41467-024-52195-8.
6
Role of gut microbiota in Crohn's disease pathogenesis: Insights from fecal microbiota transplantation in mouse model.肠道微生物群在克罗恩病发病机制中的作用:来自小鼠模型粪便微生物群移植的启示。
World J Gastroenterol. 2024 Aug 21;30(31):3689-3704. doi: 10.3748/wjg.v30.i31.3689.
7
The Effect of Protein Nutritional Support on Inflammatory Bowel Disease and Its Potential Mechanisms.蛋白质营养支持对炎症性肠病的影响及其潜在机制。
Nutrients. 2024 Jul 17;16(14):2302. doi: 10.3390/nu16142302.
8
Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options.炎症性肠病:分子基础、预测生物标志物、诊断方法和治疗选择的综合分析。
Int J Mol Sci. 2024 Jun 27;25(13):7062. doi: 10.3390/ijms25137062.
9
Non-alcoholic fatty liver disease (NAFLD) and obesity in inflammatory bowel disease (IBD) patients in Gorgan.戈尔甘炎症性肠病(IBD)患者中的非酒精性脂肪性肝病(NAFLD)与肥胖
Caspian J Intern Med. 2024 Spring;15(2):299-306. doi: 10.22088/cjim.15.2.299.
10
Pollutants, microbiota and immune system: frenemies within the gut.污染物、微生物群和免疫系统:肠道内的“亦敌亦友”。
Front Public Health. 2024 May 10;12:1285186. doi: 10.3389/fpubh.2024.1285186. eCollection 2024.

本文引用的文献

1
Challenges in IBD Research: Preclinical Human IBD Mechanisms.炎症性肠病研究面临的挑战:临床前人类 IBD 机制。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S5-S12. doi: 10.1093/ibd/izz075.
2
Challenges in IBD Research: Pragmatic Clinical Research.炎症性肠病研究面临的挑战:实用临床研究。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S40-S47. doi: 10.1093/ibd/izz085.
3
Challenges in IBD Research: Novel Technologies.炎症性肠病研究的挑战:新技术。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S24-S30. doi: 10.1093/ibd/izz077.
4
Challenges in IBD Research: Precision Medicine.炎症性肠病研究的挑战:精准医学。
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S31-S39. doi: 10.1093/ibd/izz078.
5
Novel Perceived Stress and Life Events Precede Flares of Inflammatory Bowel Disease: A Prospective 12-Month Follow-Up Study.新型感知压力和生活事件先于炎症性肠病发作:一项为期 12 个月的前瞻性随访研究。
J Crohns Colitis. 2019 Mar 30;13(4):410-416. doi: 10.1093/ecco-jcc/jjy177.
6
The Exposome: Molecules to Populations.外核组学:从分子到人群
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:107-127. doi: 10.1146/annurev-pharmtox-010818-021315. Epub 2018 Aug 10.
7
Personalised nutrition and health.个性化营养与健康。
BMJ. 2018 Jun 13;361:bmj.k2173. doi: 10.1136/bmj.k2173.
8
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3.
9
Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.与抗肿瘤坏死因子-α靶向治疗相比,延长皮质类固醇治疗与炎症性肠病的死亡率增加有关。
Am J Gastroenterol. 2018 Mar;113(3):405-417. doi: 10.1038/ajg.2017.479. Epub 2018 Jan 16.
10
Precision editing of the gut microbiota ameliorates colitis.精准编辑肠道微生物群可改善结肠炎。
Nature. 2018 Jan 11;553(7687):208-211. doi: 10.1038/nature25172. Epub 2018 Jan 3.